SAN DIEGO, Aug. 26, 2011 /PRNewswire/ — Cardium Therapeutics
(NYSE Amex:
CXM) today announced that Christopher J. Reinhard, Chairman and
Chief Executive Officer, is scheduled to present at the Southern
California Investor Conference on Monday, August 29, 2011, at 9:30
a.m. (Pacific) at the Island Hotel in Newport Beach, California.
The slide presentation will be available at the Company’s
website at
http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations.
(Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)
About CardiumCardium is focused on the acquisition and
strategic development of new and innovative bio-medical product
opportunities and businesses that have the potential to address
significant unmet medical needs and definable pathways to
commercialization, partnering and other economic monetizations.
Cardium’s current investment portfolio includes the Tissue
Repair Company, Cardium Biologics, and the Company’s in-house
MedPodium healthy lifestyle product platform. The Company’s
lead product candidates include Excellagen™ topical gel for
wound care management, and Generx® DNA-based angiogenic
biologic for patients with coronary artery disease. In
addition, consistent with its capital-efficient business model,
Cardium continues to actively evaluate new technologies and
business opportunities. In July 2009, Cardium completed the
sale of its InnerCool Therapies medical device business to Royal
Philips Electronics, the first asset monetization from the
Company’s biomedical investment portfolio. News from Cardium is
located at www.cardiumthx.com.Copyright
2011 Cardium Therapeutics, Inc. All ri
‘/>”/>
SOURCE